Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 33 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
DMX-200 for treating focal segmental glomerulosclerosis in people receiving angiotensin II receptor blocker therapy	DMX-200	Focal segmental glomerulosclerosis (FSGS)	Nephrology	2024	View \| Download
Empagliflozin for treating chronic kidney disease	Empagliflozin (Jardiance; DINAMO)	Chronic kidney disease (CKD)	Cardiovascular System , Nephrology	2022	View \| Download
Finerenone for chronic kidney disease in patients with type 2 diabetes mellitus	Finerenone (BAY 948862)	Diabetic nephropathy	Endocrine Nutritional and Metabolic Disorders , Nephrology	2020	View \| Download
Forigerimod plus Standard of Care for Systemic Lupus Erythematosus	Forigerimod acitate (Lupuzor. IPP-201101; CEP-33457)	Systemic lupus erythematosus (SLE)	Immunology , Nephrology	2018	View \| Download
Glatiramer Acetate Depot for treating relapsing forms of multiple sclerosis in adults aged 18 to 55 years	Glatiramer Acetate Depot (Copaxone)	Multiple sclerosis (MS)	Nephrology	2022	View \| Download
Imlifidase for kidney transplantation in highly sensitised patients with chronic kidney disease	Imlifidase (IdeS)	Chronic kidney disease (CKD)	Cardiovascular System , Nephrology	2019	View \| Download
Lumasiran for primary hyperoxaluria type 1 in paediatric patients aged up to 5 years	Lumasiran (ALN-GO1)	Primary hyperoxaluria	Nephrology	2019	View \| Download
Lumasiran for primary hyperoxaluria type I	Lumasiran (ALN-GO1)	Primary hyperoxaluria	Nephrology	2019	View \| Download
Nedosiran for primary hyperoxaluria	Nedosiran (DCR-PHXC)	Primary hyperoxaluria	Nephrology	2022	View \| Download
Nefecon (targeted-release budesonide formulation) for IgA Nephropathy (Berger's disease)	Budesonide targeted-release (Nefecon; PL-56)	IgA nephropathy	Immunology , Nephrology	2018	View \| Download